A detailed history of Foster Dykema Cabot & Partners, LLC transactions in Prokidney Corp Ord Shs Cl A(Cy stock. As of the latest transaction made, Foster Dykema Cabot & Partners, LLC holds 54 shares of PROK stock, worth $93. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54
Holding current value
$93
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.8 - $2.5 $97 - $135
54 New
54 $104,000

Others Institutions Holding PROK

About PROKIDNEY CORP ORD SHS CL A(CY


  • Ticker PROK
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,540,200
  • Market Cap $107M
More about PROK
Track This Portfolio

Track Foster Dykema Cabot & Partners, LLC Portfolio

Follow Foster Dykema Cabot & Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster Dykema Cabot & Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foster Dykema Cabot & Partners, LLC with notifications on news.